|
|
News Breaks | | | | October 3, 2012 | | 05:38 EDT |  | STJ | St. Jude Medical peripheral nerve stimulation study confirms benefit
St. Jude Medical announced publication of results from the first large-scale study of peripheral nerve stimulation, or PNS, of the occipital nerves in patients suffering from chronic migraine. The study results, published online by Cephalalgia the journal of the International Headache Society, show a significant reduction in pain, headache days and migraine-related disability. Conducted at 15 medical centers in the U.S., the study followed 157 participants who, on average, suffered from headache approximately 21 days per month. At 12 weeks, patients receiving PNS therapy reported an average of six fewer headache days a month. | |
|
News For STJ From The Last 14 Days Check below for free stories on STJ the last two weeks. |
|
|
| May 20, 2013 | | 11:12 EDT | | STJ | St. Jude Medical to evaluate defibrilator lead related to reported death
 Subscribe for More Information | | | May 16, 2013 | | 08:05 EDT | | STJ | St. Jude Medical's 3-D vessel reconstruction system approved in Europe
St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. | | | May 14, 2013 | | 08:09 EDT | | STJ | St. Jude Medical announces first patient enrolled in EnligHTN III study
Subscribe for More Information | | | May 9, 2013 | | 14:01 EDT | | STJ | St. Jude says analysis demonstrates safety, reliability of Optim-insulated leads
Subscribe for More Information | | | 09:27 EDT |  | STJ | Leerink's medical devices analyst holds a conference call
Subscribe for More Information | | | May 8, 2013 | | 08:09 EDT | | STJ | St. Jude Medical announces CE Mark approval of ICDs, CRT-Ds
Subscribe for More Information | |
|
|
|
|
|
|
